Immunic AG | WebDisclosure

Basculer en Français

10855	Companies
235900	Keywords
164845	Articles
126462	Press releases

Home
Companies
Immunic AG

BRIEF

published on 02/04/2025 at 12:35, 1 year 6 months ago

Immunic Announces February Participation in Key Conferences

Biotechnology Investor Engagement Immunic Conferences IMU-856 Data IMU-838 Research
BRIEF

published on 02/04/2025 at 12:35, 1 year 6 months ago

Immunic annonce sa participation à des conférences clés en février

Biotechnologie Engagement Des Investisseurs Conférences Immuniques Données IMU-856 Recherche IMU-838
PRESS RELEASE

published on 02/04/2025 at 12:30, 1 year 6 months ago

Immunic to Participate in Investor and Scientific Conferences in February
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and scientific conferences in February, presenting research on IMU-856, IMU-838, and gastrointestinal diseases

Investor Conferences Immunic Inc. Scientific Conferences IMU-856 IMU-838
BRIEF

published on 01/07/2025 at 12:35, 1 year 7 months ago

Immunic's 2024 Achievements and Future Prospects

Clinical Trials Multiple Sclerosis Vidofludimus Calcium 2024 Milestones Immunic AG
BRIEF

published on 01/07/2025 at 12:35, 1 year 7 months ago

Réalisations et perspectives d'avenir d'Immunic en 2024

Essais Cliniques Sclérose En Plaques Immunic SA Vidofludimus Calcique Étapes Clés De 2024
PRESS RELEASE

published on 01/07/2025 at 12:30, 1 year 7 months ago

Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Immunic, Inc. highlights its 2024 accomplishments and upcoming milestones, including positive trial results for vidofludimus calcium in multiple sclerosis. Strengthened team and secured private placement for future growth

Multiple Sclerosis Immunic Vidofludimus Calcium 2024 Accomplishments Upcoming Milestones
BRIEF

published on 11/26/2024 at 12:35, 1 year 8 months ago

Immunic, Inc. Set to Participate in December Investor Conference

Investor Conference Immunic, Inc. Vidofludimus Calcium Piper Sandler Small Molecule Therapies
BRIEF

published on 11/26/2024 at 12:35, 1 year 8 months ago

Immunic, Inc. s'apprête à participer à la conférence des investisseurs de décembre

Immunic, Inc. Conférence Des Investisseurs Vidofludimus Calcique Piper Sandler Thérapies À Base De Petites Molécules
PRESS RELEASE

published on 11/26/2024 at 12:30, 1 year 8 months ago

Immunic, Inc. to Participate in Investor Conference in December
Immunic, Inc. to Participate in Investor Conference in December. Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing therapies for chronic inflammatory and autoimmune diseases, announces participation in Piper Sandler 36th Annual Healthcare Conference in New York

Investor Conference Biotechnology Immunic Inc. Clinical Pipeline Autoimmune Diseases
BRIEF

published on 11/13/2024 at 12:35, 1 year 9 months ago

Immunic Publishes Phase 1/1b Trial Data of IMU-856 in The Lancet

Clinical Trial Immunic Gastroenterology IMU-856 Celiac Disease

Accesswire

Published on 08/20/2026 at 02:22, 5 hours 15 minutes ago

Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 01:00, 6 hours 37 minutes ago

Irving Resources Announces Results of AGM
Published on 08/20/2026 at 00:40, 6 hours 57 minutes ago

Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 9 hours 37 minutes ago

Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 11 hours 2 minutes ago

Revive Therapeutics Announces Proposed Shares for Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 08/20/2026 at 07:00, 36 minutes ago

1H26: Swiss Prime Site delivers a strong operating result and sustained growth; FFO I of CHF 2.15 per share (+2.4%)
Published on 08/20/2026 at 07:00, 37 minutes ago

Centiel reports strong 2026 Half-Year results and invests into future growth
Published on 08/20/2026 at 07:00, 37 minutes ago

New upcycle: SBO bookings increase in H1 despite Middle East conflict
Published on 08/20/2026 at 07:00, 37 minutes ago

NFON advances its strategic transformation in a challenging environment
Published on 08/20/2026 at 06:30, 1 hour 6 minutes ago

Pleasing operating result in first half of 2026

Les Echos

Published on 08/18/2026 at 18:00, 1 day 13 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 13 hours ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 20 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 20 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 11 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE